Vaccine-Induced Immune Thrombotic Thrombocytopenia
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Efficacy and Safety".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 149
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are releasing a Special Issue of Vaccines on vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare adverse event following immunization (AEFI) associated with COVID-19 vaccines. We aim to deepen our understanding of VITT and welcome submissions on mechanisms, clinical manifestations, diagnostic criteria, and management strategies.
The Special Issue is open for submissions until 30 September 2024. Accepted manuscripts will contribute to our understanding of VITT, benefiting healthcare professionals, researchers, and policymakers in making informed decisions.
Thank you for your contributions.
Dr. Doris F. Oberle
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine-induced immune thrombotic thrombocytopenia
- VITT
- adverse events following immunization
- AEFI
- COVID-19 vaccines
